Galapagos receives transparency notification from Federated
July 29 2016 - 4:08PM
Galapagos NV (Euronext & NASDAQ: GLPG)
received a
transparency notification from Federated Equity Management
Company of Pennsylvania .
Pursuant to Belgian transparency legislation[1],
Galapagos received a transparency notification on 26 July 2016 from
Federated Investors, Inc. and Federated Equity Management Company
of Pennsylvania, who notified that funds[2] managed by Federated
Equity Management hold 2,289,479 shares of the 46,109,508 currently
outstanding Galapagos shares. On 20 July 2016, a share sale
resulted in a decrease below the 5% notification threshold of
Galapagos' voting rights. The full transparency notice is available
on the Galapagos website.
About Galapagos Galapagos (Euronext &
NASDAQ: GLPG) is a clinical-stage biotechnology company specialized
in the discovery and development of small molecule medicines with
novel modes of action. Our pipeline comprises Phase 2, Phase 1,
pre-clinical and discovery studies in cystic fibrosis,
inflammation, fibrosis, osteoarthritis and other indications. We
have discovered and developed filgotinib: in collaboration with
Gilead we aim to bring this JAK1-selective inhibitor for
inflammatory indications to patients all over the world. Galapagos
is focused on the development and commercialization of novel
medicines that will improve people's lives. The Galapagos group,
including fee-for-service subsidiary Fidelta, has approximately 460
employees, operating from its Mechelen, Belgium headquarters and
facilities in The Netherlands, France, and Croatia. More
information at www.glpg.com.
Contacts
Investors: |
Media: |
Elizabeth Goodwin |
Evelyn
Fox |
VP IR & Corporate Communications |
Director
Communications |
+1 781 460 1784 Paul van der Horst Director IR &
Business Development +31 6 53 725 199 |
+31 6 53
591 999 communications@glpg.com |
ir@glpg.com |
|
Forward-looking statements This release
may contain forward-looking statements. Such forward-looking
statements are not guarantees of future results. These
forward-looking statements speak only as of the date of publication
of this document. Galapagos expressly disclaims any obligation to
update any forward-looking statements in this document, unless
specifically required by law or regulation.
[1] Belgian Act of 2 May 2007 on the disclosure of major
shareholdings in issuers whose shares are admitted to trading on a
regulated market.
[2] Federated Kaufmann Fund, Federated
Kaufmann Fund II and Federated Kaufmann Small Cap Fund.
HUG#2031773
Galapagos (EU:GLPG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Galapagos (EU:GLPG)
Historical Stock Chart
From Jul 2023 to Jul 2024